Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 12.5

(0.81%)

Net Income Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual net income in 2023 was -43.81 Million TWD , down -40.21% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly net income in 2024 Q2 was -9.15 Million TWD , down 0.0% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported an annual net income of -31.25 Million TWD in 2022, down -488.62% from previous year.
  • Mercury Biopharmaceutical Corporation reported an annual net income of -5.3 Million TWD in 2021, down -2428.1% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly net income of -9.15 Million TWD for 2024 Q1, up 27.12% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly net income of -9.35 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual Net Income of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year Net Income Net Income Growth
2023 -43.81 Million TWD -40.21%
2022 -31.25 Million TWD -488.62%
2021 -5.3 Million TWD -2428.1%
2020 -210 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer Net Income Comparison of Mercury Biopharmaceutical Corporation

Name Net Income Net Income Difference
Allied Biotech Corporation 97.41 Million TWD 144.98%
GeneFerm Biotechnology Co., Ltd. 124.62 Million TWD 135.159%
Easywell Biomedicals, Inc. -144.81 Million TWD 69.744%
TTY Biopharm Company Limited 1.12 Billion TWD 103.883%
Synmosa Biopharma Corporation 594.83 Million TWD 107.366%
Orient EuroPharma Co., Ltd. 143.94 Million TWD 130.44%
Center Laboratories, Inc. -995.42 Million TWD 95.598%
Tien Liang BioTech Co., Ltd. 17.73 Million TWD 347.101%
Orient Pharma Co., Ltd. 22.28 Million TWD 296.59%
InnoPharmax Inc. -70.83 Million TWD 38.14%
Johnson Chemical Pharmaceutical Works Co., Ltd. 79.7 Million TWD 154.976%
Excelsior Biopharma Inc. -91.01 Million TWD 51.856%
DV Biomed Co., Ltd. 162.91 Million TWD 126.896%
Foresee Pharmaceuticals Co., Ltd. -1.03 Billion TWD 95.772%
Handa Pharmaceuticals, Inc. 726.88 Million TWD 106.028%
UniPharma Co., Ltd. -21.81 Million TWD -100.871%
Anxo Pharmaceutical Co., Ltd. 21.86 Million TWD 300.43%
Alar Pharmaceuticals Inc. 382.61 Million TWD 111.452%
Winston Medical Supply Co., Ltd. 158.75 Million TWD 127.6%
Bioray Biotech Co., Ltd -11.55 Million TWD -279.064%
TSH Biopharm Corporation Limited 61.98 Million TWD 170.684%